Jushi Holdings (JUSHF) Other Working Capital Changes (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Other Working Capital Changes came in at -$512000.0 in Q1 2026, up 34.44% year-on-year from -$380830.5 in Q1 2025, and down 712.7% on a QoQ basis from -$63000.0 in Q4 2025.
Jushi Holdings (JUSHF) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Other Working Capital Changes data on file, last reported at -$512000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 34.44% year-over-year to -$512000.0 in Q1 2026; TTM through Mar 2026 was -$881000.0, a 153.85% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 175.96% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$512000.0, down from -$63000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for JUSHF reached as high as $3.1 million in Q2 2023 and fell as low as -$3.0 million in Q1 2023.
- Historically, Other Working Capital Changes has averaged -$128176.5 across 5 years, with a median of -$149000.0 in 2022.
- On a YoY basis, Other Working Capital Changes climbed as much as 2188.59% in 2023 and fell as far as 1045.89% in 2023.
- Year by year, Other Working Capital Changes stood at $996000.0 in 2022, then plunged by 83.94% to $160000.0 in 2023, then tumbled by 471.88% to -$595000.0 in 2024, then surged by 89.41% to -$63000.0 in 2025, then slumped by 712.7% to -$512000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$512000.0 in Q1 2026, -$63000.0 in Q4 2025, and -$703000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Sep 30, 2025 | -703,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Mar 31, 2025 | -781,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Sep 30, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |